Poly Medicure Share Price

ENCLOSED

• BSE India
• 12 hours 1 minute ago

<h3><span style="font-size:16px;"><strong>Healthcare Supplies company Poly Medicure announced Q1FY27 results</strong></span></h3><p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Consolidated Financial Highlights:</strong></p><ul><li _ngcontent-ng-c2478508423="">Revenue from Operations: The company reported revenue of Rs 52,537.55 lakh in Q1FY27, representing a YoY growth of 30.30% compared to Rs 40,321.07 lakh in Q1FY26. On a QoQ basis, revenue saw a marginal decline of 1.71% from Rs 53,451.11 lakh in Q4FY26.</li><li _ngcontent-ng-c2478508423="">Total Income: Stood at Rs 55,878.45 lakh for Q1FY27, a YoY increase of 25.60% from Rs 44,490.16 lakh in Q1FY26 and a QoQ increase of 1.18% from Rs 55,226.79 lakh in Q4FY26. For the full year FY26, total consolidated income was Rs 1,99,534.14 lakh.</li><li _ngcontent-ng-c2478508423="">Profit Before Tax (PBT): For Q1FY27, PBT was Rs 11,730.57 lakh, showing a YoY decrease of 4.59% from Rs 12,294.63 lakh in Q1FY26, but a significant QoQ increase of 37.65% compared to Rs 8,522.22 lakh in Q4FY26.</li><li _ngcontent-ng-c2478508423="">Net Profit after Tax (PAT): Recorded at Rs 8,527.43 lakh in Q1FY27, a YoY decline of 8.39% from Rs 9,308.29 lakh in Q1FY26 and a QoQ growth of 31.11% from Rs 6,504.10 lakh in Q4FY26. The consolidated PAT for FY26 stood at Rs 32,072.99 lakh.</li><li _ngcontent-ng-c2478508423="">Total Comprehensive Income: For the quarter, it was Rs 8,523.11 lakh, compared to Rs 9,239.57 lakh in Q1FY26 and Rs 8,993.90 lakh in Q4FY26.</li><li _ngcontent-ng-c2478508423="">Earnings Per Share (EPS): Basic EPS for Q1FY27 was Rs 8.49, compared to Rs 9.19 in Q1FY26 and Rs 6.54 in Q4FY26.</li></ul><p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Standalone Financial Highlights:</strong></p><ul><li _ngcontent-ng-c2478508423="">Revenue from Operations: Stood at Rs 43,109.95 lakh in Q1FY27, reflecting a YoY increase of 12.25% from Rs 38,404.67 lakh in Q1FY26, while decreasing by 2.69% QoQ from Rs 44,301.49 lakh in Q4FY26.</li><li _ngcontent-ng-c2478508423="">Total Income: Reached Rs 45,974.91 lakh in Q1FY27, up 8.14% YoY from Rs 42,514.22 lakh in Q1FY26 and up 0.35% QoQ from Rs 45,813.68 lakh in Q4FY26. For the full year FY26, total standalone income was Rs 1,78,238.25 lakh.</li><li _ngcontent-ng-c2478508423="">Profit Before Tax (PBT): Reported at Rs 11,863.94 lakh in Q1FY27, a YoY increase of 1.35% from Rs 11,706.41 lakh in Q1FY26 and a QoQ growth of 11.08% from Rs 10,680.62 lakh in Q4FY26.</li><li _ngcontent-ng-c2478508423="">Net Profit after Tax (PAT): Reached Rs 8,812.33 lakh in Q1FY27, compared to Rs 8,792.89 lakh in Q1FY26 and Rs 8,062.17 lakh in Q4FY26. Standalone PAT for FY26 was Rs 33,598.49 lakh.</li><li _ngcontent-ng-c2478508423="">Earnings Per Share (EPS): Basic EPS for Q1FY27 was Rs 8.69, nearly flat compared to Rs 8.68 in Q1FY26 and up from Rs 7.95 in Q4FY26.</li></ul><p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Business Highlights:</strong></p><ul><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Proposed Stock Split:</strong> The Board approved a sub-division (split) of the company's existing equity shares. Each existing share of face value Rs 10 will be subdivided into 2 equity shares of face value Rs 5 each.</li><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Acquisition in Brazil:</strong> During Q1FY27, the wholly-owned subsidiary Polymed Brazil LTDA acquired 100% equity in Medyneo Comercio De Produtos Para Saude LTDA for a total consideration of Rs 34.08 lakh, effective April 29, 2026.</li><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Insolvency Resolution:</strong> The Company assumed control over the operations of Himalayan Mineral Waters Private Limited (Target Company) during Q1FY27 following an NCLT order. The target company is now a wholly-owned subsidiary and its results have been consolidated.</li><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Stock Options:</strong> The Nomination & Remuneration Committee approved the grant of 1,476 stock options under the Employee Stock Option Scheme 2020. Additionally, 1,975 equity shares were allotted to employees who exercised their options under the scheme, resulting in a paid-up equity share capital of Rs 5,068.07 lakh.</li><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">QIP Proceeds Utilization:</strong> Out of the Rs 99,999.98 lakh raised via QIP in August 2024, an amount of Rs 46,505.35 lakh remains unutilized as of June 30, 2026, and is temporarily invested in liquid mutual funds, fixed deposits, and bonds.</li><li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Auditor Re-appointment:</strong> The Board approved the re-appointment of M/s Jai Prakash & Company as Cost Auditors for the financial year FY27.</li></ul><p><a class="lb" href="/gujarati/get-document/post/pdf/5771781/" target="_blank">Result PDF</a></p>

• Trendlyne
• 13 hours 35 minutes ago

The Company informed about the Resignation of Mr. Ravi Prakash the Deputy Company Secretary of the Company w.e.f. close of business hours on 10th August, 2026.

• BSE India
• 13 hours 41 minutes ago